{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:39:46Z","timestamp":1790685586813,"version":"4.1.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>A post-hoc analysis of pooled data from two Phase IIb trials (sifalimumab; NCT01283139, anifrolumab; NCT01438489) assessed the clinical significance of a Systemic Lupus Erythematosus (SLE) Responder Index (SRI(4)) response (Week 52) for 736 patients with moderate to severe SLE disease activity (study entry). SRI(4) responders achieved significantly greater improvements in clinical outcome measures (including percentages of patients with a\u2009\u2265\u20097-point reduction in SLE Disease Activity Index (SLEDAI)\u20132000 (2K), British Isles Lupus Assessment Group \u201cA\u201d or \u201c2B\u201d flare rate, and oral corticosteroid reduction to \u22647.5\u2009mg\/day; change from baseline in Physician\u2019s Global Assessment; and numbers of SLEDAI\u20132K organ domains with improvement), as well as in patient-reported outcomes (Patient\u2019s Global Assessment, Functional Assessment of Chronic Illness Therapy\u2212Fatigue; Short-Form 36 Health Survey Physical Component Summary, Mental Component Summary, Vitality domain scores) vs. nonresponders. Of patients with abnormal serologies, SRI(4) responders had numerically greater improvements (baseline to Week 52) in anti-double-stranded DNA concentrations vs. nonresponders ( p\u2009=\u20090.051), but there were no differences in C3\/C4 concentration changes between the two groups. These results confirm previous findings in a different cohort, indicating that an SRI(4) response is associated with global clinical benefit.<\/jats:p>","DOI":"10.1177\/0961203318758506","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T11:38:53Z","timestamp":1519126733000},"page":"955-962","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["Systemic Lupus Erythematosus (SLE) Responder Index response is associated with global benefit for patients with SLE"],"prefix":"10.1177","volume":"27","author":[{"given":"R","family":"Furie","sequence":"first","affiliation":[{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Northwell Health, Great Neck, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wang","sequence":"additional","affiliation":[{"name":"MedImmune, LLC, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Illei","sequence":"additional","affiliation":[{"name":"MedImmune, LLC, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Drappa","sequence":"additional","affiliation":[{"name":"MedImmune, LLC, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"bibr1-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"key":"bibr2-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12529"},{"key":"bibr3-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.186"},{"key":"bibr4-0961203318758506","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S40675"},{"key":"bibr5-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.26"},{"key":"bibr6-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1007810"},{"key":"bibr7-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144485"},{"key":"bibr8-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1002\/art.37824"},{"key":"bibr9-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket403"},{"key":"bibr10-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.10.005"},{"key":"bibr11-0961203318758506","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002795"},{"key":"bibr12-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.01.009"},{"key":"bibr13-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1002\/art.39962"},{"key":"bibr14-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208562"},{"key":"bibr15-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1186\/ar4492"},{"key":"bibr16-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1002\/art.24698"},{"key":"bibr17-0961203318758506","unstructured":"Food and Drug Administration. Guidance for Industry Systemic Lupus Erythematosus\u2014Developing medical products for treatment. Available at: https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM072063.pdf (2010, accessed 30 May 2017)."},{"key":"bibr18-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308090031"},{"key":"bibr19-0961203318758506","first-page":"504","volume":"26","author":"Smolen JS","year":"1999","journal-title":"J Rheumatol"},{"issue":"85","key":"bibr20-0961203318758506","first-page":"S85","volume":"32","author":"Castrej\u00f3n I","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"bibr21-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2"},{"key":"bibr22-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"bibr23-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000031"},{"key":"bibr24-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"bibr25-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"bibr26-0961203318758506","first-page":"288","volume":"29","author":"Gladman DD","year":"2002","journal-title":"J Rheumatol"},{"key":"bibr27-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh624"},{"key":"bibr28-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq026"},{"issue":"39","key":"bibr29-0961203318758506","first-page":"S120","volume":"23","author":"Lam GK","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"bibr30-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23889.x"},{"key":"bibr31-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.435"},{"key":"bibr32-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2010.04.017"},{"key":"bibr33-0961203318758506","doi-asserted-by":"publisher","DOI":"10.1186\/ar3250"},{"key":"bibr34-0961203318758506","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2012.66.336-339"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203318758506","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0961203318758506","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203318758506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:19:26Z","timestamp":1777677566000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0961203318758506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1177\/0961203318758506"],"URL":"https:\/\/doi.org\/10.1177\/0961203318758506","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]}}}